Abstract
It is shown that human serum albumin, previously treated with HOCl (HSA-Cl), enhances luminol-dependent chemiluminescence of neutrophils activated by phorbol-12-myristate-13-acetate (PMA). The enzyme-linked immunosorbent assay revealed that addition of HSA-Cl to neutrophils promotes exocytosis of myeloperoxidase. Inhibitor of myeloperoxidase — 4-aminobenzoic acid hydrazide, without any effect on lucigenin-dependent chemiluminescence of neutrophils stimulated with PMA, effectively suppressed luminol-dependent chemiluminescence (IC50 = 20 μM) under the same conditions. The transfer of the cells from medium with HSA-Cl and myeloperoxidase to fresh medium abolished an increase in PMA-induced luminol-dependent chemiluminescence, but not the ability of neutrophils to respond to re-addition of HSA-Cl. A direct and significant (r = 0.75, p < 0.01) correlation was observed between the intensity of PMA stimulated neutrophil chemiluminescence response and myeloperoxidase activity in the cell-free media after chemiluminescence measurements. These results suggest the involvement of myeloperoxidase in the increase of neutrophil PMA-stimulated chemiluminescence response in the presence of HSA-Cl. A significant positive correlation was found between myeloperoxidase activity in blood plasma of children with severe burns and the enhancing effects of albumin fraction of the same plasma on luminol-dependent chemiluminescence of PMA-stimulated donor neutrophils. These results support a hypothesis that proteins modified in reactions involving myeloperoxidase under oxidative/halogenative stress, stimulate neutrophils, leading to exocytosis of myeloperoxidase, a key element of halogenative stress, and to closing a “vicious circle” of neutrophil activation at the inflammatory site.
Similar content being viewed by others
References
S. J. Klebanoff, J. Leukoc. Biol. 77, 598 (2005).
O. M. Panasenko, I. V. Gorudko, A. M. Kovaleva, et al., Vestn. Yuzhn. Nauch. Tsentra RAN 6(3), 73 (2010).
O. M. Panasenko, J. Arnhold, and V. I. Sergienko, Biol. Membrany 19, 403 (2002).
O. Skaff, D. I. Pattison, and M. J. Davies, Chem. Res. Toxicol. 20, 1980 (2007).
M. D. Rees, T. N. Mcniven, and M. J. Davies, Biochem. J. 401, 587 (2007).
D. I. Pattison and M. J. Davies, Current Medicinal Chemistry 13, 3271 (2006).
C. L. Hawkins, D. I. Pattison, and M. J. Davies, Amino Acids 25, 259 (2003).
P. Salavej, H. Spalteholz, and J. Arnhold, Free Radic. Biol. Med. 40, 516 (2006).
I. V. Gorudko, T. V. Vakhrusheva, A. V. Mukhortova, et al., Biol. Membrany 27, 314 (2010).
G. Körmöczi, U. M. Wölfel, A. R. Rosenkranz, et al., J. Immunol. 167, 451 (2001).
V. Witko-Sarsat, V. Gausson, A. T. Nguyen, et al., Kidney Int. 64, 82 (2003).
L. Fialkow, Y. Wang, and G. P. Downey, Free Radic. Biol. Med. 42, 153 (2007).
R. G. Midwinter, M. C. Vissers, and C. C. Winterbourn, Arch. Biochem.Biophys. 394, 13 (2001).
A. J. Szuchman-Sapir, D. I. Pattison, M. J. Davies, and P. K. Witting, Free Radic. Biol. Med. 48, 35 (2010).
O. M. Panasenko and V. I. Sergienko, Vestn. Ross. AMN, No. 1, 27 (2010).
R. K. Schindhelm, L. P. van der Zwan, T. Teerlink, and P. G. Scheffer, Clinical Chemistry 55, 1462 (2009).
L. J. Hazell, G. Baernthaler, and R. Stocker, Free Radic. Biol. Med. 31, 1254 (2001).
E. Thomson, S. Brennan, R. Senthilmohan, et al., Free Radic. Biol. Med. 49, 1354 (2010).
H. Mita, N. Higashi, M. Taniguchi, et al., Clin. Exp. Allergy 34, 931 (2004).
M. Roche, P. Rondeau, N. R. Singh, et al., FEBS Lett. 582, 1783 (2008).
F. A. Summers, P. E. Morgan, M. J. Davies, and C. L. Hawkins, Chem. Res. Toxicol. 21, 1832 (2008).
L. R. DeChatelet, G. D. Long, P. S. Shirley, et al., J. Immunol. 129, 1589 (1982).
E. P. Brestel, Biochem. Biophys. Res. Commun. 126, 482 (1985).
O. M. Panasenko, A. V. Chekanov, I. I. Vlasova, et al., Biophysics (Moscow) 53, 268 (2008).
Y. Li, H. Zhu, P. Kuppusamy, V. Roubaud, et al., J. Biol. Chem. 273, 2015 (1998).
J. C. Morris, J. Phys. Chem. 70, 3798 (1966).
M. Gazda and D. W. Margeum, Inorg. Chem. 33, 118 (1994).
A. V. Sokolov, M. O. Pulina, K. V. Ageeva, et al., Biokhimiya 72, 506 (2007).
R. Vasileva, M. Jakob, and F. J. Hasko, Chromatogr. 216, 279 (1981).
P. C. Andrews, C. Parens, and N. I. Krinsky, Arch. Biochem. Biophys. 228, 439 (1984).
I. V. Gorudko, O. S. Cherkalina, A. V. Sokolov, et al., Bioorg. Khimiya 35, 1 (2009).
E. V. Mikhal’chik, Yu. A. Piterskaya, V. A. Lipatova, et al., Byul. Eksperim. Biol. Med. 147, 696 (2009).
E. Malle, C. Woenckhaus, G. Waeg, et al., Am. J. Pathol. 150, 603 (1997).
E. V. Mikhal’chik, L. Yu. Pen’kov, L. I. Budkevich, et al., Detskaya Khirurgiya, No. 3, 40 (2005).
J. Arnhold, S. Hammerschmidt, M. Wagner, et al., Biomed. Biochim. Acta 49, 991 (1990).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E.V. Mikhalchik, N.V. Smolina, T.S. Astamirova, I.V. Gorudko, D.V. Grigorieva, V.A. Ivanov, A.V. Sokolov, V.A. Kostevich, S.N. Cherenkevich, O.M. Panasenko, 2013, published in Biofizika, 2013, Vol. 58, No. 4, pp. 681–689.
Editor’s Note: This is a closest equivalent of the original publication with all its practical details, statements and terminology, phrasing and style, so the reader can make sound judgment; English title and Abstract provided by authors. A.G.
Rights and permissions
About this article
Cite this article
Mikhalchik, E.V., Smolina, N.V., Astamirova, T.S. et al. Human serum albumin modified under oxidative/halogenative stress enhances luminol-dependent chemiluminescence of human neutrophils. BIOPHYSICS 58, 530–536 (2013). https://doi.org/10.1134/S0006350913040118
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006350913040118